Sensory entrapment neuropathy
Conditions
Interventions
Patients will be injected with 2,5 ml methylprednisolone/lidocaine or 2,5 ml
saline 0,9% 1 cm medial of the anterior superior iliac spine after
localisation with electro stimulation of the LFCN.
Elektrostimulation
Meralgia paresthetica
Methylprednisolone/lidocaïne
Sponsors
HagaZiekenhuis
Eligibility
Age
18 Years to 64 Years
Inclusion criteria
Inclusion criteria: Adult patients with newly diagnosed idiopathic meralgia paresthetica will be recruited. Age: 18 years and older. Duration 4 weeks or more. Diagnostic criteria: Meralgia paresthetica characterized by pain, numbness and tingling in the anterolateral aspect of the thigh in the area of the LFCN
Exclusion criteria
Exclusion criteria: 1. Coexisting disorders or conditions that may mimic MP such as lumbar radiculopathy, severe polyneuropathy. 2. Known allergic reaction to methylprednisolone/lidocaine. 3. Pregnancy 4. No localization possible through electrostimulation 5. Systemic viral or fungal infections 6. Known allergy to steroids 7. No injection with steroids can be given in a vicinity of a preexistent infectious area
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary endpoint will be reduction of the pain score on a visual analogue scale (VAS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints are: - Pain reduction after injection measured on a different scale (pain worsening, no improvement of pain, slight to moderate improvement of pain, complete remission of pain.) - Duration of pain reduction - Reduction of oral analgetics ( descriptive) | — |
Countries
The Netherlands
Outcome results
None listed